» Articles » PMID: 27446059

Development of a Phage Cocktail to Control Proteus Mirabilis Catheter-associated Urinary Tract Infections

Overview
Journal Front Microbiol
Specialty Microbiology
Date 2016 Jul 23
PMID 27446059
Citations 57
Authors
Affiliations
Soon will be listed here.
Abstract

Proteus mirabilis is an enterobacterium that causes catheter-associated urinary tract infections (CAUTIs) due to its ability to colonize and form crystalline biofilms on the catheters surface. CAUTIs are very difficult to treat, since biofilm structures are highly tolerant to antibiotics. Phages have been used widely to control a diversity of bacterial species, however, a limited number of phages for P. mirabilis have been isolated and studied. Here we report the isolation of two novel virulent phages, the podovirus vB_PmiP_5460 and the myovirus vB_PmiM_5461, which are able to target, respectively, 16 of the 26 and all the Proteus strains tested in this study. Both phages have been characterized thoroughly and sequencing data revealed no traces of genes associated with lysogeny. To further evaluate the phages' ability to prevent catheter's colonization by Proteus, the phages adherence to silicone surfaces was assessed. Further tests in phage-coated catheters using a dynamic biofilm model simulating CAUTIs, have shown a significant reduction of P. mirabilis biofilm formation up to 168 h of catheterization. These results highlight the potential usefulness of the two isolated phages for the prevention of surface colonization by this bacterium.

Citing Articles

The rise, fall, and resurgence of phage therapy for urinary tract infection.

Zulk J, Patras K, Maresso A EcoSal Plus. 2024; 12(1):eesp00292023.

PMID: 39665540 PMC: 11636367. DOI: 10.1128/ecosalplus.esp-0029-2023.


Plasma activated water pre-treatment substantially enhances phage activity against biofilms.

Shambharkar A, Thompson T, McClenaghan L, Bourke P, Gilmore B, Skvortsov T Biofilm. 2024; 8:100230.

PMID: 39498232 PMC: 11532937. DOI: 10.1016/j.bioflm.2024.100230.


Synergistic effects of bacteriophage cocktail and antibiotics combinations against extensively drug-resistant Acinetobacter baumannii.

Rastegar S, Skurnik M, Tadjrobehkar O, Samareh A, Samare-Najaf M, Lotfian Z BMC Infect Dis. 2024; 24(1):1208.

PMID: 39455951 PMC: 11515142. DOI: 10.1186/s12879-024-10081-0.


Characterization and genomic analysis phage PmP19, a novel Proteus mirabilis phage with a broad host range.

Han S, Li S, Hu G, Lei M, Li C, Xiao L Arch Virol. 2024; 169(11):221.

PMID: 39412589 DOI: 10.1007/s00705-024-06154-9.


The Development of a Biomimetic Model of Bacteria Migration on Indwelling Urinary Catheter Surfaces.

Cortese Y, Fayne J, Colbert D, Devine D, Fogarty A Biomimetics (Basel). 2024; 9(8).

PMID: 39194470 PMC: 11353059. DOI: 10.3390/biomimetics9080491.


References
1.
Morris N, Stickler D, McLean R . The development of bacterial biofilms on indwelling urethral catheters. World J Urol. 2000; 17(6):345-50. DOI: 10.1007/s003450050159. View

2.
Hadas H, Einav M, Fishov I, Zaritsky A . Bacteriophage T4 development depends on the physiology of its host Escherichia coli. Microbiology (Reading). 1997; 143 ( Pt 1):179-185. DOI: 10.1099/00221287-143-1-179. View

3.
Siddiq D, Darouiche R . New strategies to prevent catheter-associated urinary tract infections. Nat Rev Urol. 2012; 9(6):305-14. DOI: 10.1038/nrurol.2012.68. View

4.
Kropinski A, Mazzocco A, Waddell T, Lingohr E, Johnson R . Enumeration of bacteriophages by double agar overlay plaque assay. Methods Mol Biol. 2008; 501:69-76. DOI: 10.1007/978-1-60327-164-6_7. View

5.
Viertel T, Ritter K, Horz H . Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens. J Antimicrob Chemother. 2014; 69(9):2326-36. DOI: 10.1093/jac/dku173. View